Buprenorphine depot (Alar Pharmaceuticals)

N/A

Report date: 2025/03/12 20:00:47

Base Information

Drug NameBuprenorphine depot (Alar Pharmaceuticals)
Drug Alias NameALA-1300INDV-6001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonistsδ-opioid receptor agonistsKappa opioid receptor antagonists +[4
TargetsNociceptin receptorδ-opioid receptorKappa opioid receptor +[4
Therapy Area/IndicationsOpioid-Related DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlar Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOpioid-Related DisordersPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A